等待开盘 10-04 09:30:00 美东时间
+0.029
+8.14%
Compass Diversified announced its Board declared quarterly cash distributions for its Series A, B, and C Preferred Shares. The Series A and B/C Preferred Shares will receive $0.453125 and $0.4921875 per share, respectively. All distributions cover the period from July 30, 2025, to October 29, 2025, and are payable on October 30, 2025, to holders recorded as of October 15, 2025. Distributions may qualify as “qualified dividends” for U.S. tax purpo...
10-02 20:10
Co-Diagnostics ( ($CODX) ) has shared an announcement. On September 30, 2025, C...
09-30 21:54
今日重点评级关注:Maxim Group:维持T Stamp"买入"评级,目标价从8美元升至12美元;Maxim Group:维持Rezolute"买入"评级,目标价从15美元升至20美元
09-22 18:44
Co-Diagnostics ( ($CODX) ) has shared an announcement. On September 17, 2025, C...
09-18 21:20
今日重点评级关注:HC Wainwright & Co.:维持Astria Therapeutics"买入"评级,目标价从16美元升至20美元;HC Wainwright & Co.:维持Avalo Therapeutics"买入"评级,目标价从15美元升至25美元
09-18 10:13
Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has
09-17 21:48
D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and maintains $10 price target.
09-17 19:44
Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partnership.
09-17 17:17
Shares of Adobe Inc. (NASDAQ:ADBE) rose sharply in pre-market trading after the...
09-12 17:19
Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has performed an
09-11 21:35